Company Filing History:
Years Active: 2013-2022
Title: Innovations of Ling-Wei Hsin in Pharmaceutical Development
Introduction
Ling-Wei Hsin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various medical conditions. With a total of 2 patents, his work is recognized for its potential impact on healthcare.
Latest Patents
Ling-Wei Hsin's latest patents include innovative compounds such as 8-phenyl-isoquinolines and pharmaceutical compositions used in the treatment of irritable bowel syndrome (IBS). A series of 8-phenyl-isoquinoline derivatives exhibit high binding affinity to the 5-HT receptor and demonstrate potent antinociceptive activity in two animal models for IBS through intraperitoneal injection or oral administration. These 5-HT receptor antagonists represent a new class of therapeutic agents for the treatment of IBS. Additionally, he has developed 8-phenylisoquinolines and pharmaceutical compositions for treating sepsis, showcasing his versatility in addressing critical health issues.
Career Highlights
Ling-Wei Hsin is affiliated with National Taiwan University, where he continues to advance his research and innovation in pharmaceuticals. His work is characterized by a commitment to improving patient outcomes through scientific discovery.
Collaborations
He collaborates with esteemed colleagues such as Ming-Jai Su and Linda Chia-Hui Yu, contributing to a dynamic research environment that fosters innovation.
Conclusion
Ling-Wei Hsin's contributions to pharmaceutical development highlight his role as a key inventor in the field. His innovative patents and collaborative efforts are paving the way for new treatments that could significantly benefit patients worldwide.